News
Celtic Pharma Holdings and PolyTherics announce investment into novel biopharmaceutical programme
|
 |
Tuesday, 26 January 10 - 11:30 AM (GMT) By Stephen Parker in Portfolio News |
| ||
Guernsey and London, 26th January 2010 – Celtic Pharma Holdings Advisors LLP (“CPHA”), the advisor to Celtic Pharma Holdings II LP (“CP2”), together with PolyTherics Limited (“PolyTherics”), innovators in precision engineering of proteins to improve their...
Celtic Pharma Holdings commits significant funding to Cantab Biopharmaceuticals to drive the development of improved biological medicines – ‘biosuperiors’; Jim Mills appointed as Cantab CEO
|
|
|
Monday, 25 January 10 - 09:00 AM (GMT) By Stephen Parker in Portfolio News |
| ||
Guernsey and London, 25th January 2010 – Celtic Pharma Holdings Advisors LLP (“CPHA”), today announces it has made significant funding available to Cantab Biopharmaceuticals Limited (“Cantab”) for the development of improved biological medicines or ‘biosuperior...
Celtic Pharma Holdings Appoints Dr. Andy Richards to its Advisory Board
|
|
|
Friday, 02 October 09 - 09:00 AM (GMT) By Stephen Parker in Team News |
| ||
Guernsey and London, 2nd October 2009 – Celtic Pharma Holdings Advisors LLP (“CPHA”), the advisor to the second Celtic Pharma fund, Celtic Pharma Holdings II LP (“CP2”), today announces it has appointed Dr. Andy Richards to its Advisory Board. Dr. Richards is one of ...
Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
|
|
|
Monday, 06 July 09 - 07:00 AM (GMT) By Stephen Parker in Portfolio News |
| ||
£13.1 million funding to drive novel antibiotics platform addressing areas of major unmet need, including hospital acquired infections Clostridium difficile and Methicillin-resistant Staphylococcus aureus ("MRSA")
Celtic Pharma Holdings announces Investment in Dialog Devices Limited
|
|
|
Monday, 02 February 09 - 07:00 AM (GMT) By Stephen Parker in Portfolio News |
| ||
Novel, non-invasive, diagnostic to reduce incidence of heart attack and stroke Guernsey and London, 2nd February 2009 – Celtic Pharma Holdings Advisors LLP (“CPHA”) today announces the completion of the first investment of the second Celtic Pharma fund, Celtic Pharma Holdings II...
Celtic Pharma Holdings announces First Close of Second Fund
|
|
|
Friday, 19 December 08 - 07:00 AM (GMT) By Stephen Parker in Fund News |
| ||
Guernsey and London, 19th December 2008 – Celtic Pharma Holdings Advisors LLP (“CPHA”) today announces the first close of the second Celtic Pharma fund, Celtic Pharma Holdings II LP (“CP2”). CPHA is a subsidiary of Beehive Capital LLP, the FSA-regulated fund manager....
... More items are available in our News Archive
